Exciting website updates coming soon!

You are unique — and so is your cancer.

SENGINE Precision Medicine, has developed the PARIS^® test to help your oncologist select a personalized treatment plan.

Many patients are put through a trial-and-error approach to cancer treatments, exposing them to toxic side effects of standardly used drugs that might not even work for them. At SENGINE we believe there is a better, more personalized way…

Applying knowledge of your treatment history, cancer type, and genomic features (if available), we choose up to 40 drugs from our comprehensive panel of 200+ commonly used chemotherapies and the most up-to-date targeted agents. The PARIS^® test then measures the drug sensitivity (how well the drug kills cells) of these chosen drugs, directly on your tumor- derived sample. Using advanced analytics, the PARIS^® test report provides a score-ranked list of the drugs tested from most effective to the least. This customized report can guide you and your oncologist in choosing the treatment that might work best for you.

Our unique approach has been able to identify effective treatment options for more than 75% of our patients.  Science Just For You^® is no longer only a dream.

As the PARIS^® test uses fresh tumor samples, it is important that you connect with us before you have a biopsy, surgery, or fluid removal.  Contact us for more detailed information and to order your PARIS^® test today.